When someone suffers a stroke, the immediate goal is to open the large blocked artery. However, even when doctors succeed in opening that main path, many patients still struggle to recover. This is often due to a problem called no-reflow. This happens when tiny, microscopic blood vessels remain blocked or damaged, preventing blood from reaching the brain cells that need it most.
Research shows this no-reflow issue affects at least 25% of patients after their main artery is reopened. These tiny blockages can be caused by several things, including clumps of cells, inflammation, or the body's own response to the injury. Because these issues are so complex, doctors currently lack a single, standard way to measure exactly how much no-reflow is happening in a patient.
While there is no standard test yet, researchers are looking into new ways to treat these small blockages. These methods focus on reducing inflammation and improving blood flow in the smallest vessels. Some experimental treatments, like selective cooling, show promise in lab models, but they are not yet standard for patients.
